Big Pharma Split Corp. (PRM.TO)
CAD 13.05
(0.0%)
CAD 13.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 311.76 Thousand | 3.71 Million | 5.35 Million | 589.25 Thousand | 2.43 Million | 3.23 Million |
| Cost of Revenue | 308.56 Thousand | 419.53 Thousand | 355.99 Thousand | 277.31 Thousand | 238.19 Thousand | 274.75 Thousand |
| Gross Profit | 3195.00 | 3.29 Million | 5 Million | 311.94 Thousand | 2.19 Million | 2.95 Million |
| Operating Expenses | 311.76 Thousand | 565.12 Thousand | 505.73 Thousand | 323.83 Thousand | 396.46 Thousand | 452.01 Thousand |
| Selling, General and Administrative Expenses | 334.55 Thousand | 357.75 Thousand | 370.56 Thousand | 216.24 Thousand | 287.07 Thousand | 319.98 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 207.37 Thousand | 135.16 Thousand | 107.58 Thousand | 109.39 Thousand | 132.03 Thousand |
| Cost and Expenses | 311.76 Thousand | 565.12 Thousand | 505.73 Thousand | 323.83 Thousand | 634.65 Thousand | 726.76 Thousand |
| Operating Income | -139.68 Thousand | 3.14 Million | 4.85 Million | 265.42 Thousand | 454.66 Thousand | 5.94 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -645.35 Thousand | 2.38 Million | 4.2 Million | -217.38 Thousand | -1.34 Million | 3.16 Million |
| Earnings before Tax | -645.35 Thousand | 3.14 Million | 4.85 Million | 265.42 Thousand | 3.14 Million | 2.78 Million |
| Net Income | -139.68 Thousand | 3.14 Million | 4.85 Million | 265.42 Thousand | 4.48 Million | 2.78 Million |
| Earnings Per Share Basic | -0.53 | 1.58 | 3.27 | -0.22 | 3.75 | 2.06 |
| Earnings Per Share Diluted | -0.53 | 1.58 | 3.27 | -0.22 | 3.75 | 2.06 |
| Weighted Average Shares Outstanding | 1.21 Million | 1.5 Million | 1.28 Million | 995.8 Thousand | 1.19 Million | 1.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.21 Million | 1.5 Million | 1.28 Million | 995.8 Thousand | 1.19 Million | 1.35 Million |
| Gross Margin | 0.01 | 0.89 | 0.93 | 0.53 | 0.90 | 0.91 |
| EBIT Margin | - | 0.85 | 0.91 | 0.45 | 0.19 | 2.82 |
| Profit Margin | -0.45 | 0.85 | 0.91 | 0.45 | 1.84 | 0.86 |
| EBITDA | - | -3.37 Million | - | - | 454.66 Thousand | 2.1 Million |
| Earnings Before Tax Margin | -0.45 | 0.85 | 0.91 | 0.45 | 0.19 | 1.84 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.11 Million | 991.2 Thousand | 311.76 Thousand | 359.61 Thousand | 2.2 Million | -199.2 Thousand |
| Cost of Revenue | 162.1 Thousand | 148.94 Thousand | 308.56 Thousand | - | 159.62 Thousand | - |
| Gross Profit | 951.33 Thousand | 842.25 Thousand | 3195.00 | 359.61 Thousand | 2.04 Million | -199.2 Thousand |
| Operating Expenses | -550.92 Thousand | 662.87 Thousand | 451.44 Thousand | 269.91 Thousand | 2.36 Million | 39.67 Thousand |
| Selling, General and Administrative Expenses | - | 151.59 Thousand | - | 151.59 Thousand | 137.75 Thousand | 137.75 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 550.92 Thousand | -662.87 Thousand | -3.02 Million | - | -2.36 Million | - |
| Cost and Expenses | -388.82 Thousand | 811.81 Thousand | 451.44 Thousand | 269.91 Thousand | 2.52 Million | 39.67 Thousand |
| Operating Income | 1.5 Million | 179.38 Thousand | -139.68 Thousand | 184.78 Thousand | -319.07 Thousand | -366.4 Thousand |
| Interest Expense | 266.36 Thousand | - | - | - | - | - |
| Income Tax Expense | - | -223.81 Thousand | -645.35 Thousand | -223.81 Thousand | 82.75 Thousand | 82.75 Thousand |
| Earnings before Tax | 1.23 Million | -78.05 Thousand | -139.68 Thousand | -39.02 Thousand | -567.3 Thousand | -283.65 Thousand |
| Net Income | 1.23 Million | -78.05 Thousand | -139.68 Thousand | -39.02 Thousand | -567.3 Thousand | -283.65 Thousand |
| Earnings Per Share Basic | 0.99 | -0.07 | - | -0.03 | -0.45 | -0.23 |
| Earnings Per Share Diluted | 0.99 | -0.07 | - | -0.03 | -0.45 | -0.23 |
| Weighted Average Shares Outstanding | 1.24 Million | 1.16 Million | 1.21 Million | 1.18 Million | 1.24 Million | 1.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.24 Million | 1.16 Million | 1.21 Million | 1.18 Million | 1.24 Million | 1.24 Million |
| Gross Margin | 0.85 | 0.85 | 0.01 | 1.00 | 0.93 | 1.00 |
| EBIT Margin | 1.35 | 0.18 | - | -0.62 | -0.14 | -0.42 |
| Profit Margin | 1.11 | -0.08 | -0.45 | -0.11 | -0.26 | 1.42 |
| EBITDA | 1.5 Million | 179.38 Thousand | - | -223.81 Thousand | -319.07 Thousand | 82.75 Thousand |
| Earnings Before Tax Margin | 1.35 | 0.18 | -0.45 | 0.51 | -0.14 | 1.84 |
YVIT
FDGMF
CGABL
0GC0
1003
DAR